Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer

NCT00004083 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: cisplatin liposomal

Sponsor

NYU Langone Health

Collaborators

[object Object]